{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:01:18Z","timestamp":1780124478507,"version":"3.54.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021855","name":"University of Ioannina","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021855","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract infections in early infancy, and the recent introduction of two novel immunoprophylaxis tools\u2014maternal vaccination with the RSVpreF vaccine and infant protection with the long-acting monoclonal antibody nirsevimab\u2014represents a major advancement in RSV prevention. The successful implementation of these strategies depends heavily on pediatricians\u2019 awareness, confidence, and readiness to integrate them into routine clinical practice. Evidence from Southern Europe remains limited. This cross-sectional study assessed the knowledge, attitudes, and practices of pediatricians in Crete, Greece, regarding RSV infection and emerging prevention tools. A structured electronic questionnaire was distributed between April and July 2025 to all board-certified pediatricians and pediatric residents registered with the regional medical associations. Among 169 respondents (mean age 46\u2009\u00b1\u200912.5\u00a0years; 83.4% women), overall knowledge was high, with a mean score of 89.6\u2009\u00b1\u200910.0. Knowledge gaps were concentrated in areas related to newly introduced immunoprophylaxis tools, including awareness of RSV monoclonal antibody availability for infants, updated recommendations covering infants up to 6\u00a0months, and distinctions between palivizumab and nirsevimab. Attitudes toward vaccination were overwhelmingly positive: nearly all participants expressed strong vaccine confidence and adherence to national immunization guidelines. Most pediatricians (78.6%) felt adequately informed about RSV. These findings suggest that pediatricians in Crete possess a strong foundation for integrating new RSV prevention strategies, although targeted educational initiatives\u2014particularly regarding nirsevimab\u2014will be essential to ensure consistent and equitable implementation. The results provide timely insights to support national planning and optimize the rollout of RSV immunoprophylaxis in Greece and comparable settings.\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\n                              <jats:italic>RSV is a leading cause of severe respiratory disease in early infancy.<\/jats:italic>\n                              \u2022\n                              <jats:italic>New prevention tools (RSVpreF, nirsevimab) are being introduced into national programs.<\/jats:italic>\n                              \u2022\n                              <jats:italic>Pediatricians\u2019 knowledge and confidence strongly influence vaccine uptake.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Greek pediatricians show high overall RSV knowledge and strong vaccine confidence.<\/jats:italic>\n                              \u2022\n                              <jats:italic>Specific gaps exist regarding nirsevimab and distinctions between immunoprophylaxis tools.<\/jats:italic>\n                              \u2022\n                              <jats:italic>Findings highlight targeted education needs during early implementation of RSV prevention.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-026-06977-5","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T03:16:59Z","timestamp":1777259819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knowledge, attitudes, and practices of pediatricians in Crete, Greece, regarding RSV immunization: a cross-sectional study"],"prefix":"10.1007","volume":"185","author":[{"given":"D.","family":"Vrentzos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Pavlopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Syrogiannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Grivea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1090-3698","authenticated-orcid":false,"given":"F.","family":"Ladomenou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"16","key":"6977_CR1","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","volume":"388","author":"B Kampmann","year":"2023","unstructured":"Kampmann B, Madhi SA, Munjal I et al (2023) Bivalent pre-fusion F vaccine in pregnancy to prevent RSV illness in infants. N Engl J Med 388(16):1451\u20131464. https:\/\/doi.org\/10.1056\/NEJMoa2216480","journal-title":"N Engl J Med"},{"issue":"6","key":"6977_CR2","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.4161\/hv.24096","volume":"9","author":"P Kaaijk","year":"2013","unstructured":"Kaaijk P, Luytjes W, Rots NY (2013) Is maternal vaccination a good alternative to other approaches? Hum Vaccin Immunother 9(6):1263\u20131267. https:\/\/doi.org\/10.4161\/hv.24096","journal-title":"Hum Vaccin Immunother"},{"issue":"10359","key":"6977_CR3","first-page":"67","volume":"400","author":"Y Li","year":"2022","unstructured":"Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ et al (2022) Global, regional, and national disease burden estimates of respiratory syncytial virus in infants younger than 6 months: a systematic analysis. Lancet 400(10359):67\u201379","journal-title":"Lancet"},{"key":"6977_CR4","unstructured":"European Medicines Agency. Beyfortus: EPAR \u2013 Product information. Amsterdam: EMA. 2022. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/beyfortus. Accessed 31 Jan 2025"},{"key":"6977_CR5","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1056\/NEJMc2214773","volume":"388","author":"WJ Muller","year":"2023","unstructured":"Muller WJ, Madhi SA, Seoane Nunez B, Baca Cots M, Bosheva M, Dagan R et al (2023) Nirsevimab for prevention of RSV in term and late-preterm infants. N Engl J Med 388:1533\u20131534. https:\/\/doi.org\/10.1056\/NEJMc2214773","journal-title":"N Engl J Med"},{"key":"6977_CR6","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1056\/NEJMoa2309189","volume":"389","author":"SB Drysdale","year":"2023","unstructured":"Drysdale SB, Cathie K, Flamein F, Knuf M, Collins AM, Hill HC et al (2023) Nirsevimab for prevention of hospitalizations due to RSV in infants. N Engl J Med 389:2425\u20132435. https:\/\/doi.org\/10.1056\/NEJMoa2309189","journal-title":"N Engl J Med"},{"key":"6977_CR7","unstructured":"European Medicines Agency. Abrysvo: EPAR \u2013 Product information. Amsterdam: EMA; 2023. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/abrysvo"},{"issue":"25","key":"6977_CR8","doi-asserted-by":"publisher","first-page":"00624","DOI":"10.1016\/S1473-3099(25)00624-3","volume":"S1473\u20133099","author":"I McLachlan","year":"2025","unstructured":"McLachlan I, Robertson C, Morrison KE, McQueenie R, Shahul Hameed S, Gibbons C et al (2025) Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case-control study and cohort analysis. Lancet Infect Dis S1473\u20133099(25):00624\u201300633. https:\/\/doi.org\/10.1016\/S1473-3099(25)00624-3","journal-title":"Lancet Infect Dis"},{"key":"6977_CR9","unstructured":"Hellenic Ministry of Health. National Immunization Programme for Adults \u2013 Greece, 2025. Athens: Ministry of Health; 2024. Available from: https:\/\/www.moh.gov.gr"},{"key":"6977_CR10","unstructured":"Hellenic Ministry of Health. National Immunization Programme for Children and Adolescents \u2013 Greece, 2025. Athens: Ministry of Health; 2024. Available from: https:\/\/www.moh.gov.gr"},{"issue":"47","key":"6977_CR11","doi-asserted-by":"publisher","first-page":"6420","DOI":"10.1016\/j.vaccine.2015.08.046","volume":"33","author":"RJ Wilson","year":"2015","unstructured":"Wilson RJ, Paterson P, Jarrett C, Larson HJ (2015) Understanding factors influencing vaccination acceptance during pregnancy globally. Vaccine 33(47):6420\u20136429","journal-title":"Vaccine"},{"issue":"9","key":"6977_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13090896","volume":"13","author":"S Esposito","year":"2025","unstructured":"Esposito S, Fainardi V, Capra ME et al (2025) Acceptance of nirsevimab for the prevention of respiratory syncytial virus infection in neonates: a cross-sectional survey in Emilia-Romagna, Italy. Vaccines 13(9):896","journal-title":"Vaccines"},{"issue":"52","key":"6977_CR13","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.1016\/j.vaccine.2016.10.042","volume":"34","author":"P Paterson","year":"2016","unstructured":"Paterson P, Meurice F, Stanberry LR, Glismann S, Rosenthal SL, Larson HJ (2016) Vaccine hesitancy and healthcare providers. Vaccine 34(52):6700\u20136706","journal-title":"Vaccine"},{"key":"6977_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1686581","volume":"13","author":"M H\u00f6ck","year":"2025","unstructured":"H\u00f6ck M, Borena W, Brunner J et al (2025) Acceptance and impact of nirsevimab and the RSVpreF vaccine following implementation in Austria. Front Public Health 13:1686581. https:\/\/doi.org\/10.3389\/fpubh.2025.1686581","journal-title":"Front Public Health"},{"issue":"1","key":"6977_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s44250-025-00198-7","volume":"4","author":"T Morris","year":"2025","unstructured":"Morris T, Acevedo K, Alvarez Alde\u00e1n J, Fiscus M, Hackell J, P\u00e9rez Mart\u00edn J et al (2025) Lessons from implementing a long-acting monoclonal antibody (nirsevimab) for RSV in France, Spain and the US. Discover Health Systems 4(1):21. https:\/\/doi.org\/10.1007\/s44250-025-00198-7","journal-title":"Discover Health Systems"},{"issue":"15","key":"6977_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare12151536","volume":"12","author":"D Papagiannis","year":"2024","unstructured":"Papagiannis D, Tiganis N, Kotsiou OS, Lampropoulos IC, Fradelos EC, Malli F et al (2024) Assessment of knowledge, attitudes, and vaccination practices regarding the new RSV vaccine among health professionals in Greece. Healthcare (Basel) 12(15):1536. https:\/\/doi.org\/10.3390\/healthcare12151536","journal-title":"Healthcare (Basel)"},{"key":"6977_CR17","unstructured":"Hellenic National Public Health Organization. National vaccination surveillance data. Athens: EODY; 2021\u20132023. Available from: https:\/\/eody.gov.gr"},{"issue":"34","key":"6977_CR18","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","volume":"33","author":"NE MacDonald","year":"2015","unstructured":"MacDonald NE, SAGE Working Group on Vaccine Hesitancy (2015) Vaccine hesitancy: definition, scope and determinants. Vaccine 33(34):4161\u20134164","journal-title":"Vaccine"},{"issue":"1","key":"6977_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/pediatric15010013","volume":"15","author":"M Ricc\u00f2","year":"2023","unstructured":"Ricc\u00f2 M, Corrado S, Cerviere MP, Ranzieri S, Marchesi F (2023) Respiratory syncytial virus prevention through monoclonal antibodies: a cross-sectional study on knowledge, attitudes, and practices of Italian pediatricians. Pediatr Rep 15(1):154\u2013174. https:\/\/doi.org\/10.3390\/pediatric15010013","journal-title":"Pediatr Rep"},{"key":"6977_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-024-01593-1","volume":"50","author":"G Congedo","year":"2024","unstructured":"Congedo G, Lombardi GS, Zjalic D, Di Russo M, La Gatta E, Regazzi L et al (2024) Knowledge, attitudes and behaviours of a sample of Italian paediatricians towards RSV and its preventive strategies: a cross-sectional study. Ital J Pediatr 50:35. https:\/\/doi.org\/10.1186\/s13052-024-01593-1","journal-title":"Ital J Pediatr"},{"issue":"2","key":"6977_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.24953\/turkjpediatr.2025.5528","volume":"67","author":"\u0130 Y\u0131ld\u0131z","year":"2025","unstructured":"Y\u0131ld\u0131z \u0130, G\u00f6n\u00fcll\u00fc E, Y\u0131lmaz S, Zengin E, Ye\u015filba\u015f O, Soysal A (2025) Turkish pediatricians\u2019 knowledge, attitudes, and awareness of respiratory syncytial virus (RSV) infection and immunization strategies: a cross-sectional study. Turk J Pediatr 67(2):153\u2013161. https:\/\/doi.org\/10.24953\/turkjpediatr.2025.5528","journal-title":"Turk J Pediatr"},{"key":"6977_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-01021-2","volume":"15","author":"D Mrcela","year":"2025","unstructured":"Mrcela D, Deng S, Li Y, Jukic I, Markic J (2025) Knowledge, attitudes, and practices of Croatian pediatricians and pediatrics residents about RSV infection. Sci Rep 15:15838. https:\/\/doi.org\/10.1038\/s41598-025-01021-2","journal-title":"Sci Rep"},{"issue":"1","key":"6977_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2498264","volume":"21","author":"Y Choi","year":"2025","unstructured":"Choi Y, Berjonneau E, Vincent B, Dwyer B, Chun B, Petigara T et al (2025) Assessment of physicians\u2019 perception of pediatric respiratory syncytial virus disease and preferences for immunization strategies in the United States. Hum Vaccin Immunother 21(1):2498264. https:\/\/doi.org\/10.1080\/21645515.2025.2498264","journal-title":"Hum Vaccin Immunother"},{"key":"6977_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2026.128374","volume":"77","author":"F Ladomenou","year":"2026","unstructured":"Ladomenou F, Matalliotakis M (2026) Closing the maternal immunization gap: strengthening antenatal care in Southern Europe. Vaccine 77:128374. https:\/\/doi.org\/10.1016\/j.vaccine.2026.128374","journal-title":"Vaccine"},{"key":"6977_CR25","doi-asserted-by":"publisher","unstructured":"Damatopoulou A, Matalliotakis M, Diamanta Y, Pikrides I, Ierapetritis E, Kakouri P et al (2024) Prospective attitudes towards respiratory syncytial virus (RSV) vaccine in pregnant women in Greece. Behav Med. https:\/\/doi.org\/10.1080\/08964289.2024.2424171","DOI":"10.1080\/08964289.2024.2424171"},{"key":"6977_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1033486","volume":"9","author":"C Berkhout","year":"2022","unstructured":"Berkhout C, Berbra O, Favre J et al (2022) Defining and evaluating the Hawthorne effect in primary care: a systematic review and meta-analysis. Front Med 9:1033486","journal-title":"Front Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06977-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-06977-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06977-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:02:38Z","timestamp":1780120958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-06977-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["6977"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-06977-5","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the 7th Health Region of Greece, which is the competent regional authority for the island of Crete and was conducted in accordance with the principles of the Declaration of Helsinki. All participants were informed about the purpose and procedures of the study prior to their involvement. Participation was entirely voluntary, and respondents were assured that their answers would remain anonymous and confidential. Completion and submission of the questionnaire were considered to constitute informed consent. No identifiable personal data were collected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"305"}}